Vaccines Market Introduces New Vaccine With A Capability Of Preventing Possible Number Of Infections With Single Vaccine

Vaccines Market, Spurred By Growing Prevalence Of Diseases & Increasing Adoption Of Vaccines, Predicted To Continue Till The End Of The Forecast Period.

According to the latest report “Vaccines Market: By Type (Monovalent, Multivalent); By Technology (Conjugate Vaccines, Inactivated and Subunit Vaccines, Others); By Disease Indication (Pneumococcal Disease, DTP, Others); By End User (Paediatrics, Adults) & Region-Forecast (2016-2022)”, published by IndustryARC, estimates that Asia-Pacific will register the fastest growth over the forecast period.

Browse Market Report @

Vaccine is a biological preparation that is used for prevention of infectious diseases. The vaccination saves provides better and healthier life to millions of lives including adults, children and animals. World Health Organization and many other international organizations had approved the vaccination as the one of the bes methods for the prevention of infectious diseases. There are different kinds of vaccines present in the market like polio vaccine, rubella vaccine, chickenpox vaccine, TB vaccine, yellow fever vaccine, typhoid vaccine and many others. Rising prevalence of diseases is the major factor that leads high growth for the Vaccines Market.

Scope & Regional Forecast of the Vaccines Market

Development of efficient and advanced vaccines, rise in the awareness among people regarding the benefits of immunization, increasing government initiatives across the globe, growing prevalence of diseases, and increasing demand for better health-care infrastructure are the prime growth drivers of the Vaccines Market.

However, higher cost of research and development, and risk of side effects of vaccines in some cases are the key restraints for the Vaccines Market. But increase in adoption of vaccines for children in nations like China, India and others are creating new opportunities for the market. Among all the end users, paediatrics segment has the highest market share in the market.

North America is dominating the Vaccines Market, because approximately half of the world’s procedures being done in US because of high medical reimbursement facilities and also due to technological advancement. Asia-Pacific is projected to witness the fastest growth due to increasing population, rising consumer awareness, modernization of health-care infrastructure and favorable government policies.

Request For Table Of Contents @

Segmentations & Key Players Involved in the Vaccines Market

The Vaccines Market can be broken down into various segmentations on the basis of –

  • Type: Monovalent Vaccines and Multivalent Vaccines.

  • Technology: Conjugate Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Toxoid Vaccines and Recombinant Vaccines.

  • Diseases Indication: Pneumococcal Disease, DTP, Influenza, Human Papilloma Virus, Meningococcal Disease, Polio, Rotavirus, Hepatitis, MMR, Varicella and Others.

  • End-User: Paediatrics and Adults.

  • Region: Europe, Asia Pacific, North America and Rest of the World.

Some of the key players involved in the Vaccines Market are as follows:

  • Astellas Pharma Inc.

  • Emergent Biosolutions, Inc.

  • Sanofi Pasteur

  • Glaxosmithkline, PLC.

  • CSL Limited

Why buy this report?

* The overall market has been consolidated from the perspective of different geographic locations and key economies for this market.

* Identifies growth sectors and factors driving or constraining the market.

* The market is analyzed based on the key attributes such as the power in the hands of producers and consumers, analysis on the degree of competition, and threats from substitutes and new entrants.

* The study includes the demand of this particular market on a global and regional scale for a six year period of 2016 – 2022, to assess how the market will develop.

Make an Inquiry @

Media Contact
Company Name: IndustryARC
Contact Person: Mr. Venkateshwar Reddy
Email: Send Email
Phone: 1-614-588-8538 (Ext: 101)
Country: United States